Literature DB >> 11121731

Structure-activity relationship of P-glycoprotein substrates and modifiers.

A Seelig1, E Landwojtowicz.   

Abstract

The air-water partition coefficients, K(aw), highly correlated with the corresponding lipid-water partition coefficients, K(lw), and the critical micelle concentrations, CMC, were measured for 11 compounds for which the kinetic parameters of P-glycoprotein ATPase activation (Michaelis-Menten constant, K(m), and maximal velocity, V(max)) had been determined previously in inside-out vesicles of CR1R12 Chinese hamster ovary cells. In addition, the hydrogen bond donor patterns (type I and type II) relevant for substrate recognition by P-glycoprotein were determined from the energy-minimized three-dimensional structure of these compounds. A linear relation between the air-water partition coefficient, K(aw), and the inverse of the Michaelis-Menten constant, K(m), was observed such that K(m) x K(aw) approximately = 1. The maximal velocity, V(max), was shown to decrease with the number and strength of electron donor (hydrogen bond acceptor) groups in recognition patterns. If two substrates are applied simultaneously to P-glycoprotein the compound with the higher potential to form hydrogen bonds generally acts as an inhibitor. We conclude that partitioning into the lipid membrane is the rate-limiting step for the interaction of a substrate with P-glycoprotein and that dissociation of the P-glycoprotein-substrate complex is determined by the number and strength of the hydrogen bonds formed between the substrate and the transporter.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11121731     DOI: 10.1016/s0928-0987(00)00177-9

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  43 in total

Review 1.  Theoretical predictions of drug absorption in drug discovery and development.

Authors:  Patric Stenberg; Christel A S Bergström; Kristina Luthman; Per Artursson
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

2.  P-glycoprotein-ATPase modulation: the molecular mechanisms.

Authors:  Xiaochun Li-Blatter; Andreas Beck; Anna Seelig
Journal:  Biophys J       Date:  2012-03-20       Impact factor: 4.033

Review 3.  Coexistence of passive and carrier-mediated processes in drug transport.

Authors:  Kiyohiko Sugano; Manfred Kansy; Per Artursson; Alex Avdeef; Stefanie Bendels; Li Di; Gerhard F Ecker; Bernard Faller; Holger Fischer; Grégori Gerebtzoff; Hans Lennernaes; Frank Senner
Journal:  Nat Rev Drug Discov       Date:  2010-08       Impact factor: 84.694

4.  Exploring the P-glycoprotein binding cavity with polyoxyethylene alkyl ethers.

Authors:  Xiaochun Li-Blatter; Anna Seelig
Journal:  Biophys J       Date:  2010-12-01       Impact factor: 4.033

5.  The elementary mass action rate constants of P-gp transport for a confluent monolayer of MDCKII-hMDR1 cells.

Authors:  Thuy Thanh Tran; Aditya Mittal; Tanya Aldinger; Joseph W Polli; Andrew Ayrton; Harma Ellens; Joe Bentz
Journal:  Biophys J       Date:  2004-10-22       Impact factor: 4.033

Review 6.  Efflux transporters as a novel herbivore countermechanism to plant chemical defenses.

Authors:  Jennifer S Sorensen; M Denise Dearing
Journal:  J Chem Ecol       Date:  2006-05-23       Impact factor: 2.626

Review 7.  Role of P-glycoprotein in pharmacokinetics: clinical implications.

Authors:  Jiunn H Lin; Masayo Yamazaki
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

8.  The DrrAB efflux system of Streptomyces peucetius is a multidrug transporter of broad substrate specificity.

Authors:  Wen Li; Madhu Sharma; Parjit Kaur
Journal:  J Biol Chem       Date:  2014-03-14       Impact factor: 5.157

9.  A biophysical approach to daunorubicin interaction with model membranes: relevance for the drug's biological activity.

Authors:  Ana Catarina Alves; Daniela Ribeiro; Miguel Horta; José L F C Lima; Cláudia Nunes; Salette Reis
Journal:  J R Soc Interface       Date:  2017-08       Impact factor: 4.118

10.  A novel chalcone derivative which acts as a microtubule depolymerising agent and an inhibitor of P-gp and BCRP in in-vitro and in-vivo glioblastoma models.

Authors:  Ahcene Boumendjel; Anne McLeer-Florin; Pierre Champelovier; Diane Allegro; Dima Muhammad; Florence Souard; Madiha Derouazi; Vincent Peyrot; Bertrand Toussaint; Jean Boutonnat
Journal:  BMC Cancer       Date:  2009-07-20       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.